Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Leukemia & Lymphoma
|
February 26, 1999
Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma
T Robak, J Gora-Tybor, H Urbańska-Ryś, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
November 1, 1971
[Studies on blastic lymphocyte transformation in cultures in chronic lymphocytic leukemia]
A Pluzańska, E Kulesza, E Krykowski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
December 1, 1971
[Blastic transformation of lymphocytes in P. H. A.-stimulated cultures in cases of lymphosarcoma and reticulosarcoma and its clinical significance]
A Pluzańska, E Polkowska-Kulesza, H Krauze-Jaworska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1997
2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia
K Warzocha, K Fabianowska-Majewska, J Bloński, et al.
Patologia Polska
|
October 1, 1980
[Angioimmunoblastic lymphadenopathy as a paraneoplastic syndrome in stomach cancer]
E Polkowska-Kulesza, E Krykowski, L Woźniak, et al.
Annals of Hematology
|
May 25, 2002
Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system
E Kalinka, T Robak, A Wrzesien-Kus, et al.
European Journal of Haematology
|
February 1, 1997
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine)
T Robak, M Błasińska-Morawiec, E Krykowski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
October 1, 1991
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]
M Błasińska-Morawiec, A Płuzańska, E Krykowski, et al.
Neoplasma
|
August 26, 1998
Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease
P Smolewski, H Niewiadomska, J Z Błonski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
November 1, 1980
[Acetylation phenotype in systemic lupus erythematosus]
B Orłowska-Westwood, J Skretkowicz, D Orszulak, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Leukemia & Lymphoma
|
February 26, 1999
Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma
T Robak, J Gora-Tybor, H Urbańska-Ryś, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
November 1, 1971
[Studies on blastic lymphocyte transformation in cultures in chronic lymphocytic leukemia]
A Pluzańska, E Kulesza, E Krykowski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
December 1, 1971
[Blastic transformation of lymphocytes in P. H. A.-stimulated cultures in cases of lymphosarcoma and reticulosarcoma and its clinical significance]
A Pluzańska, E Polkowska-Kulesza, H Krauze-Jaworska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1997
2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia
K Warzocha, K Fabianowska-Majewska, J Bloński, et al.
Patologia Polska
|
October 1, 1980
[Angioimmunoblastic lymphadenopathy as a paraneoplastic syndrome in stomach cancer]
E Polkowska-Kulesza, E Krykowski, L Woźniak, et al.
Annals of Hematology
|
May 25, 2002
Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system
E Kalinka, T Robak, A Wrzesien-Kus, et al.
European Journal of Haematology
|
February 1, 1997
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine)
T Robak, M Błasińska-Morawiec, E Krykowski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
October 1, 1991
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]
M Błasińska-Morawiec, A Płuzańska, E Krykowski, et al.
Neoplasma
|
August 26, 1998
Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease
P Smolewski, H Niewiadomska, J Z Błonski, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
November 1, 1980
[Acetylation phenotype in systemic lupus erythematosus]
B Orłowska-Westwood, J Skretkowicz, D Orszulak, et al.
Page
of 11